Stock comparison
Mettler-Toledo International
Veracyte
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
VCYT
Veracyte
Market cap
$3.59B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | VCYT | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 50D | MTD |
| Benjamin Graham | 65B | 61D | MTD |
| Philip Fisher | 63C | 65C | VCYT |
| Peter Lynch | 66B | 72B | VCYT |
| Joel Greenblatt | 68B | 50D | MTD |
| Charlie Munger | 74B | 51D | MTD |
| Terry Smith | 70B | 56D | MTD |
Side-by-side metrics
| Metric | MTD | VCYT |
|---|---|---|
| Market cap | $22.29B | $3.59B |
| P/E (TTM) | 25.3x | 34.8x |
| EV/EBIT | 21.6x | 38.4x |
| ROIC (TTM) | 36.09% | 4.73% |
| Gross margin | 57.79% | 71.31% |
| Net margin | 21.4% | 16.25% |
| Revenue CAGR 5y | 2.01% | 23.89% |
| EPS CAGR 5y | 6.12% | - |
| Debt / Equity | - | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 0.0x+100%
- ROIC (TTM)36.09%vs 4.73%+87%
- Market cap$22.29Bvs $3.59B+84%
- EV/EBIT21.6xvs 38.4x+44%
VCYT leads on
- Revenue CAGR 5y23.89%vs 2.01%+92%
- Gross margin71.31%vs 57.79%+19%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.